ONCOLOGY RESEARCH

简称 ONCOL RES ·UNITED STATES ·出版周期 Monthly ·年均收录 83 篇

4.1

最新影响因子

3.40%

自引率

约75%

投稿难度

平均3月

审稿周期

期刊简介

ONCOLOGY RESEARCH是一本专注于肿瘤学领域的国际学术期刊，ISSN号为0965-0407，由美国出版商Cognizant Communication Corporation出版，出版地为美国，出版周期为月刊。该期刊的影响因子根据年份有所不同，近年来的影响因子在2-3之间波动。ONCOLOGY RESEARCH目前不是完全开放获取（OA）期刊，但部分文章可能提供开放获取选项。该期刊被SCI收录，属于中科院分区中的医学大类，具体分区可能因年份和评估标准而有所变化，通常位于3区或4区。杂志的发文特点主要集中在肿瘤学的基础与临床研究，涵盖肿瘤生物学、分子靶向治疗、免疫治疗、肿瘤流行病学等领域，尤其关注创新性研究和转化医学应用。杂志的质量中等，适合发表肿瘤学相关的研究成果，但需注意其影响因子相对较低，学术影响力有限，可能存在审稿周期较长或录用标准不稳定的风险。总体而言，ONCOLOGY RESEARCH为肿瘤学研究者提供了一个发表成果的平台，但投稿前建议结合自身研究方向和期刊的近期表现进行综合评估。

影响因子趋势

近期发表

Targeting SRC/STAT3 Signaling Impairs Cancer Stem Cell Activity by Downregulation of Hexokinase-2 in Radioresistant Triple-Negative Breast Cancer Cells 2026-03-03

SDHA Deficiency in Hepatocellular Carcinoma Promotes Tumor Progression through Succinate-Induced M2 Macrophage Polarization 2025-12-08

RP11-Derived Long Non-Coding RNAs in Hepatocellular Carcinoma: Hidden Treasures in Plain Sight 2025-11-21

Metal-Based Therapeutic Approaches for Overcoming Cancer Drug Resistance: Mechanisms, Drug Delivery Strategies, and Clinical Perspectives 2026-03-26

MicroRNA320e Augments the Synthetic Lethality of Olaparib by Regulating the PI3K-AKT-mTOR Pathway 2026-07-27

The Frontier of Melanoma Treatment: Defeating Immunotherapy Resistance—A Systematic Review 2026-01-04

Monoclonal Antibodies and Derivatives: Therapeutic Tools for Cancer 2026-04-30

Pan-Cancer Analysis of Enhancer-Induced PAN3-AS1 and Experimental Validation as a WFDC13-Promoting Factor in Colon Cancer 2025-11-14

Detection of Prostate Carcinoma in an Asymptomatic Individual Initiated by an Immunological Biopsy—A Case Report 2025-12-25

miR-320d Is Associated with Reduced Nasopharyngeal Carcinoma Progression, Potentially through the NF-κB/IL-8 Axis-Mediated Inhibition of Neutrophil Extracellular Trap Formation 2026-07-01